全文获取类型
收费全文 | 2869篇 |
免费 | 211篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 105篇 |
妇产科学 | 105篇 |
基础医学 | 376篇 |
口腔科学 | 42篇 |
临床医学 | 426篇 |
内科学 | 375篇 |
皮肤病学 | 95篇 |
神经病学 | 267篇 |
特种医学 | 75篇 |
外国民族医学 | 2篇 |
外科学 | 379篇 |
综合类 | 25篇 |
预防医学 | 354篇 |
眼科学 | 56篇 |
药学 | 180篇 |
肿瘤学 | 185篇 |
出版年
2021年 | 35篇 |
2020年 | 28篇 |
2019年 | 38篇 |
2018年 | 36篇 |
2017年 | 44篇 |
2016年 | 48篇 |
2015年 | 58篇 |
2014年 | 66篇 |
2013年 | 142篇 |
2012年 | 158篇 |
2011年 | 160篇 |
2010年 | 73篇 |
2009年 | 86篇 |
2008年 | 148篇 |
2007年 | 170篇 |
2006年 | 148篇 |
2005年 | 147篇 |
2004年 | 147篇 |
2003年 | 134篇 |
2002年 | 151篇 |
2001年 | 69篇 |
2000年 | 53篇 |
1999年 | 58篇 |
1998年 | 41篇 |
1997年 | 28篇 |
1996年 | 36篇 |
1995年 | 35篇 |
1994年 | 32篇 |
1993年 | 35篇 |
1992年 | 56篇 |
1991年 | 54篇 |
1990年 | 54篇 |
1989年 | 43篇 |
1988年 | 35篇 |
1987年 | 39篇 |
1986年 | 23篇 |
1985年 | 33篇 |
1984年 | 44篇 |
1983年 | 26篇 |
1982年 | 20篇 |
1981年 | 19篇 |
1980年 | 19篇 |
1979年 | 26篇 |
1978年 | 11篇 |
1977年 | 10篇 |
1973年 | 10篇 |
1972年 | 15篇 |
1971年 | 18篇 |
1970年 | 15篇 |
1969年 | 19篇 |
排序方式: 共有3083条查询结果,搜索用时 15 毫秒
1.
Bernard Natukunda Grace Ndeezi Lay See Er Francis Bajunirwe Gayle Teramura Meghan Delaney 《ISBT科学丛刊》2019,14(4):366-373
2.
3.
Christine M Sapienza Michael P Cannito Thomas Murry Ryan Branski Gayle Woodson 《J. Speech Lang. Hear. Res.》2002,45(5):830-843
Acoustic analysis of a reading passage was used to identify the abnormal phonatory events associated with adductor spasmodic dysphonia (ADSD) pre- and postinjection of Botulinum Toxin A (Botox). Thirty-one patients (age 22 to 74 years) diagnosed with ADSD were included for study. All patients were new recipients of Botox, and the examination of their voice occurred before and after their initial injection of Botox. Acoustic events were identified from reading samples of the Rainbow Passage produced by each of the patients. These events were examined from sentences containing primarily voiced sound segments. Dependent variables included the number of phonatory breaks, frequency shifts, and aperiodic segments--all variables previously defined by the investigators. Additionally, calculated variables were made of the percentage of time these events occurred relative to the duration of the cumulative voiced segments. A sex- and age-matched control group (+/-2 years) was included for statistical comparison. Results indicated that those with ADSD produced more aberrant acoustic events than the controls. Aperiodicity was the predominant acoustic event produced during the reading, followed by frequency shifts and phonatory breaks. Within the ADSD group, the number of atypical acoustic events decreased following Botox injection. It is important that the occurrence of specific abnormal acoustic events was sufficient to differentiate the disordered speakers from the controls following as well as preceding initial Botox injection, as indicated by discriminant function analysis. This paper complements our previous work using this acoustic analysis method for defining the abnormal events present in the voice of those with ADSD and further suggests that these measures can be used in conjunction with perceptual impressions to differentiate speakers on the basis of initial severity. 相似文献
4.
The influence of protein solubilisation, conformation and size on the burst release from poly(lactide-co-glycolide) microspheres. 总被引:5,自引:0,他引:5
Gayle Duncan Thomas J Jess Farahidah Mohamed Nicholas C Price Sharon M Kelly Christopher F van der Walle 《Journal of controlled release》2005,110(1):34-48
Encapsulation of proteins in poly(lactide-co-glycolide) microspheres via emulsion is known to cause insoluble protein aggregates. Following protein emulsification and encapsulation in PLGA microspheres, we used circular dichroism to show that the recoverable soluble protein fraction also suffers subtle conformational changes. For a panel of proteins selected on the basis of molecular size and structural class, conformational stability measured by chemical denaturation was not indicative of stability during emulsion-encapsulation. Partial loss of structure was observed for alpha-helical proteins released from freeze-dried microspheres in aqueous buffer, with dramatic loss of structure for a beta-sandwich protein. The addition of sucrose (a lyoprotectant) did not prevent the loss of protein conformation upon encapsulation. Therefore, the conformational changes seen for the released soluble protein fraction originates during emulsification rather than microsphere freeze-drying. Analysis of the burst release for all proteins in buffer containing denaturant or surfactant showed that the degree of protein solubilisation was the dominant factor in determining the initial rate and extent of release. Our data for protein release into increasing concentrations of denaturing buffer suggest that the emulsion-denatured protein fraction remains insoluble; this fraction may represent the protein loss encountered upon comparison of protein encapsulated versus protein released. 相似文献
5.
6.
7.
8.
This study determined the accuracy of fit of three-unit fixed partial dentures joined by an infrared soldering technique compared with one-piece fixed partial denture castings and individually cast crowns. Wax patterns of prepared Ivorine teeth, maxillary left central incisor and maxillary left canine, were injection molded; a plastic rod was used as a pontic. One group of patterns was cast as one-piece dentures; the other group was sectioned in the connector area, cast individually and then joined by infrared soldering. Castings were seated on their respective dies, embedded in epoxy resin, and sectioned. Gap distances between the casting and the die were measured at specified marginal sites with a profile projector. Results showed that the fit of infrared-soldered fixed partial dentures was significantly better than that of one-piece castings and was comparable with the fit of single crowns. The gap openings measured in all castings were within the range of clinical acceptability. 相似文献
9.
Dr. Andrew G. Bostom M.D. Dr. Anne L. Hume Pharm.D. Dr. Charles B. Eaton M.D. Dr. Joseph P. Laurino Ph.D. Ms. Lisa R. Yanek B.A. Ms. Mary S. Regan B.S. Mr. William H. McQuade M.P.H. Dr. Wendy Y. Craig Ph.D. Ms. Gayle Perrone M.B.A. Dr. Paul F. Jacques Sc.D. 《Pharmacotherapy》1995,15(4):458-464
Study Objective . To determine the efficacy of high-dose ascorbate supplementation in lowering lipoprotein(a) [Lp(a)] levels in patients with premature coronary heart disease (CHD). Design . Randomized, double-blind, placebo-controlled trial. Setting . Outpatient clinic. Patients . Forty-four patients with documented premature CHD. defined as confirmed myocardial infarction and/or angiographically determined stenosis of 50% or greater in at least one major coronary artery before age 60 years. Interventions . Patients were block randomized on the basis of age, gender, and screening Lp(a) concentrations to receive ascorbate 4.5 g/day or placebo for 12 weeks. Measurements and Main Results . High-dose ascorbate was well tolerated and produced a marked elevation in mean plasma ascorbate levels (+1.2 mg/dl; p<0.001). Multiple linear regression analysis revealed no significant effect of supplementation on postintervention Lp(a) levels (p=0.39) in a model that included treatment group assignment, and baseline Lp(a) levels. Conclusions . Our findings do not support a clinically important lowering effect of high-dose ascorbate on plasma Lp(a) in patients with premature CHD. 相似文献
10.